Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesoblast Ltd (MESO)
NASDAQ:MESO
Holding MESO?
Track your performance easily
MESO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.61 - $8.66
Previous Close$6.19
Volume103.42K
Average Volume (3M)158.99K
Market Cap
$709.89M
Enterprise Value$754.87M
Total Cash (Recent Filing)$71.51M
Total Debt (Recent Filing)$116.50M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Nov 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.89
Shares Outstanding114,178,411
10 Day Avg. Volume76,865
30 Day Avg. Volume158,990
Standard Deviation0.35
R-Squared0.26
Alpha-0.00319
Financial Highlights & Ratios
Price to Book (P/B)1.46
Price to Sales (P/S)127.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue133.68
Enterprise Value/Gross Profit100.64
Enterprise Value/Ebitda-16.45
Forecast
1Y Price Target
$11.00Price Target Upside71.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Mesoblast News
PremiumCompany Announcements
Mesoblast Anticipates FDA Decisions, Manages Finances
PremiumCompany Announcements
Mesoblast’s Ryoncil® Awaits FDA Approval for SR-aGVHD
Ownership Overview
0.00%
Insiders
<0.01% Mutual Funds
0.55% Other Institutional Investors
99.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MESO FAQ
What was Mesoblast Ltd’s price range in the past 12 months?
Mesoblast Ltd lowest stock price was $1.61 and its highest was $8.66 in the past 12 months.
What is Mesoblast Ltd’s market cap?
Currently, no data Available
When is Mesoblast Ltd’s upcoming earnings report date?
Mesoblast Ltd’s upcoming earnings report date is Nov 20, 2024 which is in 61 days.
How were Mesoblast Ltd’s earnings last quarter?
Mesoblast Ltd released its earnings results on Aug 28, 2024. The company reported -$0.5 earnings per share for the quarter, missing the consensus estimate of -$0.3 by -$0.2.
Is Mesoblast Ltd overvalued?
According to Wall Street analysts Mesoblast Ltd’s price is currently Undervalued.
Does Mesoblast Ltd pay dividends?
Mesoblast Ltd does not currently pay dividends.
What is Mesoblast Ltd’s EPS estimate?
Mesoblast Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mesoblast Ltd have?
Mesoblast Ltd has 114,124,120 shares outstanding.
What happened to Mesoblast Ltd’s price movement after its last earnings report?
Mesoblast Ltd reported an EPS of -$0.5 in its last earnings report, missing expectations of -$0.3. Following the earnings report the stock price went up 1.57%.
Which hedge fund is a major shareholder of Mesoblast Ltd?
Currently, no hedge funds are holding shares in MESO
---
Mesoblast Stock Smart Score
Company Description
Mesoblast Ltd
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
---
MESO Company Deck
---
MESO Earnings Call
Q4 2024
0:00 / 0:00
---
MESO Stock 12 Month Forecast
Average Price Target
$11.00
▲(71.61% Upside)
Technical Analysis
Best Analysts Covering MESO
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-31.62%
reiterated a buy rating 22 days ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -31.62% per trade.
---